Compile Data Set for Download or QSAR

Found 164 hits with Last Name = 'stankovic' and Initial = 'cj'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Caspase-1 (Homo sapiens (Human))	BDBM12066 ((3S)-3-({2-[4-(butan-2-yl)-3-methylphenoxy]benzene...) Show SMILES CCC(C)c1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1C |r| Show InChI InChI=1S/C21H25NO6S/c1-4-14(2)18-10-9-17(11-15(18)3)28-19-7-5-6-8-20(19)29(26,27)22-16(13-23)12-21(24)25/h5-11,13-14,16,22H,4,12H2,1-3H3,(H,24,25)/t14?,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	100	-41.6	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12064 ((3S)-3-({2-[3-methyl-4-(propan-2-yl)phenoxy]benzen...) Show SMILES CC(C)c1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1C |r| Show InChI InChI=1S/C20H23NO6S/c1-13(2)17-9-8-16(10-14(17)3)27-18-6-4-5-7-19(18)28(25,26)21-15(12-22)11-20(23)24/h4-10,12-13,15,21H,11H2,1-3H3,(H,23,24)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	110	-41.3	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12070 ((3S)-4-oxo-3-{[2-(4-phenylphenoxy)benzene]sulfonam...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1Oc1ccc(cc1)-c1ccccc1)C=O |r| Show InChI InChI=1S/C22H19NO6S/c24-15-18(14-22(25)26)23-30(27,28)21-9-5-4-8-20(21)29-19-12-10-17(11-13-19)16-6-2-1-3-7-16/h1-13,15,18,23H,14H2,(H,25,26)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	290	-38.8	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12062 ((3S)-4-oxo-3-({2-[3-(propan-2-yl)phenoxy]benzene}s...) Show SMILES CC(C)c1cccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)c1 |r| Show InChI InChI=1S/C19H21NO6S/c1-13(2)14-6-5-7-16(10-14)26-17-8-3-4-9-18(17)27(24,25)20-15(12-21)11-19(22)23/h3-10,12-13,15,20H,11H2,1-2H3,(H,22,23)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	410	-37.9	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12058 ((3S)-3-{[2-(3-methylphenoxy)benzene]sulfonamido}-4...) Show SMILES Cc1cccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)c1 |r| Show InChI InChI=1S/C17H17NO6S/c1-12-5-4-6-14(9-12)24-15-7-2-3-8-16(15)25(22,23)18-13(11-19)10-17(20)21/h2-9,11,13,18H,10H2,1H3,(H,20,21)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	430	-37.8	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12067 ((3S)-4-oxo-3-({2-[4-(pentan-3-yl)phenoxy]benzene}s...) Show SMILES CCC(CC)c1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1 |r| Show InChI InChI=1S/C21H25NO6S/c1-3-15(4-2)16-9-11-18(12-10-16)28-19-7-5-6-8-20(19)29(26,27)22-17(14-23)13-21(24)25/h5-12,14-15,17,22H,3-4,13H2,1-2H3,(H,24,25)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	440	-37.7	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12061 ((3S)-4-oxo-3-{[2-(3,4,5-trimethylphenoxy)benzene]s...) Show SMILES Cc1cc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc(C)c1C |r| Show InChI InChI=1S/C19H21NO6S/c1-12-8-16(9-13(2)14(12)3)26-17-6-4-5-7-18(17)27(24,25)20-15(11-21)10-19(22)23/h4-9,11,15,20H,10H2,1-3H3,(H,22,23)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	450	-37.7	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12065 ((3S)-3-({2-[4-(butan-2-yl)phenoxy]benzene}sulfonam...) Show SMILES CCC(C)c1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1 |r| Show InChI InChI=1S/C20H23NO6S/c1-3-14(2)15-8-10-17(11-9-15)27-18-6-4-5-7-19(18)28(25,26)21-16(13-22)12-20(23)24/h4-11,13-14,16,21H,3,12H2,1-2H3,(H,23,24)/t14?,16-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	490	-37.5	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12063 ((3S)-4-oxo-3-({2-[4-(propan-2-yl)phenoxy]benzene}s...) Show SMILES CC(C)c1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1 |r| Show InChI InChI=1S/C19H21NO6S/c1-13(2)14-7-9-16(10-8-14)26-17-5-3-4-6-18(17)27(24,25)20-15(12-21)11-19(22)23/h3-10,12-13,15,20H,11H2,1-2H3,(H,22,23)/t15-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	620	-36.9	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12068 ((3S)-3-{[2-(4-cyclopentylphenoxy)benzene]sulfonami...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1Oc1ccc(cc1)C1CCCC1)C=O |r| Show InChI InChI=1S/C21H23NO6S/c23-14-17(13-21(24)25)22-29(26,27)20-8-4-3-7-19(20)28-18-11-9-16(10-12-18)15-5-1-2-6-15/h3-4,7-12,14-15,17,22H,1-2,5-6,13H2,(H,24,25)/t17-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	880	-36.0	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12069 ((3S)-3-{[2-(4-cyclohexylphenoxy)benzene]sulfonamid...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1Oc1ccc(cc1)C1CCCCC1)C=O |r| Show InChI InChI=1S/C22H25NO6S/c24-15-18(14-22(25)26)23-30(27,28)21-9-5-4-8-20(21)29-19-12-10-17(11-13-19)16-6-2-1-3-7-16/h4-5,8-13,15-16,18,23H,1-3,6-7,14H2,(H,25,26)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	900	-35.9	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12060 ((3S)-3-{[2-(2,3-dimethylphenoxy)benzene]sulfonamid...) Show SMILES Cc1cccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)c1C |r| Show InChI InChI=1S/C18H19NO6S/c1-12-6-5-8-15(13(12)2)25-16-7-3-4-9-17(16)26(23,24)19-14(11-20)10-18(21)22/h3-9,11,14,19H,10H2,1-2H3,(H,21,22)/t14-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.00E+3	-35.6	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12059 ((3S)-3-{[2-(4-methylphenoxy)benzene]sulfonamido}-4...) Show SMILES Cc1ccc(Oc2ccccc2S(=O)(=O)N[C@@H](CC(O)=O)C=O)cc1 |r| Show InChI InChI=1S/C17H17NO6S/c1-12-6-8-14(9-7-12)24-15-4-2-3-5-16(15)25(22,23)18-13(11-19)10-17(20)21/h2-9,11,13,18H,10H2,1H3,(H,20,21)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.10E+3	-35.4	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12055 ((3S)-4-oxo-3-[(2-phenylbenzene)sulfonamido]butanoi...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1-c1ccccc1)C=O |r| Show InChI InChI=1S/C16H15NO5S/c18-11-13(10-16(19)20)17-23(21,22)15-9-5-4-8-14(15)12-6-2-1-3-7-12/h1-9,11,13,17H,10H2,(H,19,20)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	1.60E+3	-34.4	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12056 ((3S)-4-oxo-3-[(2-phenoxybenzene)sulfonamido]butano...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1Oc1ccccc1)C=O |r| Show InChI InChI=1S/C16H15NO6S/c18-11-12(10-16(19)20)17-24(21,22)15-9-5-4-8-14(15)23-13-6-2-1-3-7-13/h1-9,11-12,17H,10H2,(H,19,20)/t12-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	2.40E+3	-33.4	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12057 ((3S)-3-{[2-(2-methylphenoxy)benzene]sulfonamido}-4...) Show SMILES Cc1ccccc1Oc1ccccc1S(=O)(=O)N[C@@H](CC(O)=O)C=O |r| Show InChI InChI=1S/C17H17NO6S/c1-12-6-2-3-7-14(12)24-15-8-4-5-9-16(15)25(22,23)18-13(11-19)10-17(20)21/h2-9,11,13,18H,10H2,1H3,(H,20,21)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	3.00E+3	-32.8	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
Caspase-1 (Homo sapiens (Human))	BDBM12071 (4-[4-(2-{[(2S)-1-carboxy-3-oxopropan-2-yl]sulfamoy...) Show SMILES OC(=O)C[C@H](NS(=O)(=O)c1ccccc1Oc1ccc(cc1)-c1ccc(cc1)C(O)=O)C=O |r| Show InChI InChI=1S/C23H19NO8S/c25-14-18(13-22(26)27)24-33(30,31)21-4-2-1-3-20(21)32-19-11-9-16(10-12-19)15-5-7-17(8-6-15)23(28)29/h1-12,14,18,24H,13H2,(H,26,27)(H,28,29)/t18-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	4.20E+3	-31.9	n/a	n/a	n/a	n/a	n/a	7.0	37
Pfizer					Assay Description The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...				Bioorg Med Chem Lett 11: 2779-82 (2001) Article DOI: 10.1016/s0960-894x(01)00573-x BindingDB Entry DOI: 10.7270/Q26W9896
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491689 (CHEMBL2387425) Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:22| Show InChI InChI=1S/C27H33N7O3/c1-27(2,3)24-22-23(34(32-24)11-12-35)25(36)28-16-20(31-22)17-7-8-21(37-4)19(13-17)18-14-29-26(30-15-18)33-9-5-6-10-33/h7-8,13-15,35H,5-6,9-12,16H2,1-4H3,(H,28,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D (Homo sapiens (Human))	BDBM50491647 (CHEMBL2387019) Show SMILES CCC(CC)c1nn(CC)c2c1N=C(CNC2=O)c1ccc(cc1)C(O)=O |c:13| Show InChI InChI=1S/C20H24N4O3/c1-4-12(5-2)16-17-18(24(6-3)23-16)19(25)21-11-15(22-17)13-7-9-14(10-8-13)20(26)27/h7-10,12H,4-6,11H2,1-3H3,(H,21,25)(H,26,27)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491682 (CHEMBL2387423) Show SMILES COc1ccc(cc1-c1cnc(cc1C)N(C)C)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C27H34N6O3/c1-16-12-22(32(5)6)28-14-19(16)18-13-17(8-9-21(18)36-7)20-15-29-26(35)24-23(30-20)25(27(2,3)4)31-33(24)10-11-34/h8-9,12-14,34H,10-11,15H2,1-7H3,(H,29,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491698 (CHEMBL2387426) Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCOCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:23| Show InChI InChI=1S/C27H33N7O4/c1-27(2,3)24-22-23(34(32-24)7-10-35)25(36)28-16-20(31-22)17-5-6-21(37-4)19(13-17)18-14-29-26(30-15-18)33-8-11-38-12-9-33/h5-6,13-15,35H,7-12,16H2,1-4H3,(H,28,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491681 (CHEMBL2387427) Show SMILES COc1ccc(c(OC)n1)-c1cc(ccc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C26H31N5O5/c1-26(2,3)23-21-22(31(30-23)11-12-32)24(33)27-14-18(28-21)15-7-9-19(34-4)17(13-15)16-8-10-20(35-5)29-25(16)36-6/h7-10,13,32H,11-12,14H2,1-6H3,(H,27,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.80	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491680 (CHEMBL2387429) Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCCCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:23| Show InChI InChI=1S/C28H35N7O3/c1-28(2,3)25-23-24(35(33-25)12-13-36)26(37)29-17-21(32-23)18-8-9-22(38-4)20(14-18)19-15-30-27(31-16-19)34-10-6-5-7-11-34/h8-9,14-16,36H,5-7,10-13,17H2,1-4H3,(H,29,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491693 (CHEMBL2387428) Show SMILES COc1ccc(cc1-c1cnc(nc1)N(C)C)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:19| Show InChI InChI=1S/C25H31N7O3/c1-25(2,3)22-20-21(32(30-22)9-10-33)23(34)26-14-18(29-20)15-7-8-19(35-6)17(11-15)16-12-27-24(28-13-16)31(4)5/h7-8,11-13,33H,9-10,14H2,1-6H3,(H,26,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.5	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491679 (CHEMBL2387430 | US11419874, Example 3) Show SMILES COc1ccc(cc1-c1cnc(OC)nc1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:18| Show InChI InChI=1S/C24H28N6O4/c1-24(2,3)21-19-20(30(29-21)8-9-31)22(32)25-13-17(28-19)14-6-7-18(33-4)16(10-14)15-11-26-23(34-5)27-12-15/h6-7,10-12,31H,8-9,13H2,1-5H3,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.30	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491694 (CHEMBL2385104) Show SMILES COc1ccc(c(OC)c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C27H32N4O5/c1-27(2,3)25-23-24(31(30-25)11-12-32)26(33)28-15-20(29-23)16-7-10-21(35-5)19(13-16)18-9-8-17(34-4)14-22(18)36-6/h7-10,13-14,32H,11-12,15H2,1-6H3,(H,28,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.40	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491651 (CHEMBL2387143) Show SMILES COc1ccc(Cc2nn3c(nc(C)c3c(=O)[nH]2)[C@@H](CCc2ccccc2)[C@@H](C)O)cc1OO |r| Show InChI InChI=1S/C25H28N4O5/c1-15-23-25(31)27-22(14-18-10-12-20(33-3)21(13-18)34-32)28-29(23)24(26-15)19(16(2)30)11-9-17-7-5-4-6-8-17/h4-8,10,12-13,16,19,30,32H,9,11,14H2,1-3H3,(H,27,28,31)/t16-,19+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491699 (CHEMBL2387422) Show SMILES COc1ccc(cc1-c1cnn(C)c1)C1=Nc2c(C(=O)NC1)n(CCO)nc2C(C)(C)C |t:16| Show InChI InChI=1S/C23H28N6O3/c1-23(2,3)21-19-20(29(27-21)8-9-30)22(31)24-12-17(26-19)14-6-7-18(32-5)16(10-14)15-11-25-28(4)13-15/h6-7,10-11,13,30H,8-9,12H2,1-5H3,(H,24,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.80	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491690 (CHEMBL2387441) Show SMILES COc1ccc(cc1-c1cnc(OC)nc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C26H32N6O5/c1-26(2,3)22-20-21(32(31-22)10-7-11-33)23(34)27-14-18(29-20)15-8-9-19(35-4)16(12-15)17-13-28-25(37-6)30-24(17)36-5/h8-9,12-13,33H,7,10-11,14H2,1-6H3,(H,27,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491697 (CHEMBL2387424) Show SMILES COc1ccc(cc1-c1cnc(OC)nc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C25H30N6O5/c1-25(2,3)21-19-20(31(30-21)9-10-32)22(33)26-13-17(28-19)14-7-8-18(34-4)15(11-14)16-12-27-24(36-6)29-23(16)35-5/h7-8,11-12,32H,9-10,13H2,1-6H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	9.30	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491692 (CHEMBL2387436) Show SMILES COc1ccc(c(OC)c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H34N4O5/c1-28(2,3)26-24-25(32(31-26)12-7-13-33)27(34)29-16-21(30-24)17-8-11-22(36-5)20(14-17)19-10-9-18(35-4)15-23(19)37-6/h8-11,14-15,33H,7,12-13,16H2,1-6H3,(H,29,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491683 (CHEMBL2387440) Show SMILES COc1ccc(cc1-c1cnc(cc1C)N(C)C)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H36N6O3/c1-17-13-23(33(5)6)29-15-20(17)19-14-18(9-10-22(19)37-7)21-16-30-27(36)25-24(31-21)26(28(2,3)4)32-34(25)11-8-12-35/h9-10,13-15,35H,8,11-12,16H2,1-7H3,(H,30,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491645 (CHEMBL2387135) Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(OC)c(OC)c1 |c:14| Show InChI InChI=1S/C21H28N4O4/c1-5-13(6-2)18-19-20(25(24-18)9-10-26)21(27)22-12-15(23-19)14-7-8-16(28-3)17(11-14)29-4/h7-8,11,13,26H,5-6,9-10,12H2,1-4H3,(H,22,27)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D (Homo sapiens (Human))	BDBM50491650 (CHEMBL2387020) Show SMILES CC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(F)cc1 |c:13| Show InChI InChI=1S/C18H21FN4O2/c1-18(2,3)16-14-15(23(22-16)8-9-24)17(25)20-10-13(21-14)11-4-6-12(19)7-5-11/h4-7,24H,8-10H2,1-3H3,(H,20,25)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491684 (CHEMBL2387439) Show SMILES COc1ccc(cc1-c1cnn(C)c1)C1=Nc2c(C(=O)NC1)n(CCCO)nc2C(C)(C)C |t:16| Show InChI InChI=1S/C24H30N6O3/c1-24(2,3)22-20-21(30(28-22)9-6-10-31)23(32)25-13-18(27-20)15-7-8-19(33-5)17(11-15)16-12-26-29(4)14-16/h7-8,11-12,14,31H,6,9-10,13H2,1-5H3,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	36	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491695 (CHEMBL2387437) Show SMILES COc1ccc(cc1-c1ccc(cc1)C(O)=O)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:19| Show InChI InChI=1S/C27H30N4O5/c1-27(2,3)24-22-23(31(30-24)12-5-13-32)25(33)28-15-20(29-22)18-10-11-21(36-4)19(14-18)16-6-8-17(9-7-16)26(34)35/h6-11,14,32H,5,12-13,15H2,1-4H3,(H,28,33)(H,34,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491644 (CHEMBL2387139) Show SMILES CCC(CC)c1nn(CCCO)c2c1N=C(CNC2=O)c1ccccc1 |c:15| Show InChI InChI=1S/C20H26N4O2/c1-3-14(4-2)17-18-19(24(23-17)11-8-12-25)20(26)21-13-16(22-18)15-9-6-5-7-10-15/h5-7,9-10,14,25H,3-4,8,11-13H2,1-2H3,(H,21,26)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491643 (CHEMBL2387140) Show SMILES CCC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-5-23(3,4)21-19-20(29(27-21)12-13-30)22(31)25-14-18(26-19)16-6-8-17(9-7-16)28-11-10-24-15(28)2/h6-11,30H,5,12-14H2,1-4H3,(H,25,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid PDB UniChem	PDB Article PubMed	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair				3D Structure (crystal)
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491643 (CHEMBL2387140) Show SMILES CCC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-5-23(3,4)21-19-20(29(27-21)12-13-30)22(31)25-14-18(26-19)16-6-8-17(9-7-16)28-11-10-24-15(28)2/h6-11,30H,5,12-14H2,1-4H3,(H,25,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid PDB UniChem	PDB Article PubMed	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair				3D Structure (crystal)
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491685 (CHEMBL2387435) Show SMILES COc1ccc(OC)c(c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H34N4O5/c1-28(2,3)26-24-25(32(31-26)12-7-13-33)27(34)29-16-21(30-24)17-8-10-22(36-5)19(14-17)20-15-18(35-4)9-11-23(20)37-6/h8-11,14-15,33H,7,12-13,16H2,1-6H3,(H,29,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	46	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D (Homo sapiens (Human))	BDBM50491645 (CHEMBL2387135) Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(OC)c(OC)c1 |c:14| Show InChI InChI=1S/C21H28N4O4/c1-5-13(6-2)18-19-20(25(24-18)9-10-26)21(27)22-12-15(23-19)14-7-8-16(28-3)17(11-14)29-4/h7-8,11,13,26H,5-6,9-10,12H2,1-4H3,(H,22,27)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	48	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491646 (CHEMBL2387021) Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-4-16(5-2)20-21-22(29(27-20)12-13-30)23(31)25-14-19(26-21)17-6-8-18(9-7-17)28-11-10-24-15(28)3/h6-11,16,30H,4-5,12-14H2,1-3H3,(H,25,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	54	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491691 (CHEMBL2387438) Show SMILES COc1ccc(cn1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:18| Show InChI InChI=1S/C26H31N5O4/c1-26(2,3)24-22-23(31(30-24)11-6-12-32)25(33)28-15-19(29-22)16-7-9-20(34-4)18(13-16)17-8-10-21(35-5)27-14-17/h7-10,13-14,32H,6,11-12,15H2,1-5H3,(H,28,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	70	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D (Homo sapiens (Human))	BDBM50491653 (CHEMBL2387136) Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccccc1 |c:14| Show InChI InChI=1S/C19H24N4O2/c1-3-13(4-2)16-17-18(23(22-16)10-11-24)19(25)20-12-15(21-17)14-8-6-5-7-9-14/h5-9,13,24H,3-4,10-12H2,1-2H3,(H,20,25)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	76	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491652 (CHEMBL2387138) Show SMILES CCC(CC)c1nn(CCCO)c2c1N=C(CNC2=O)c1ccc(OC)c(OC)c1 |c:15| Show InChI InChI=1S/C22H30N4O4/c1-5-14(6-2)19-20-21(26(25-19)10-7-11-27)22(28)23-13-16(24-20)15-8-9-17(29-3)18(12-15)30-4/h8-9,12,14,27H,5-7,10-11,13H2,1-4H3,(H,23,28)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	93	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491648 (CHEMBL2387142) Show SMILES CC(C)c1nccn1-c1ccc(cc1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:16| Show InChI InChI=1S/C24H30N6O2/c1-15(2)22-25-10-11-29(22)17-8-6-16(7-9-17)18-14-26-23(32)20-19(27-18)21(24(3,4)5)28-30(20)12-13-31/h6-11,15,31H,12-14H2,1-5H3,(H,26,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	97	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491653 (CHEMBL2387136) Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccccc1 |c:14| Show InChI InChI=1S/C19H24N4O2/c1-3-13(4-2)16-17-18(23(22-16)10-11-24)19(25)20-12-15(21-17)14-8-6-5-7-9-14/h5-9,13,24H,3-4,10-12H2,1-2H3,(H,20,25)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	102	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human))	BDBM50491642 (CHEMBL2387141) Show SMILES CCC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1cc(C)nc1C |c:14| Show InChI InChI=1S/C24H30N6O2/c1-6-24(4,5)22-20-21(30(28-22)11-12-31)23(32)25-13-19(27-20)17-7-9-18(10-8-17)29-14-15(2)26-16(29)3/h7-10,14,31H,6,11-13H2,1-5H3,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	105	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE2 (unknown origin)				Bioorg Med Chem Lett 23: 3438-42 (2013) Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human))	BDBM50491699 (CHEMBL2387422) Show SMILES COc1ccc(cc1-c1cnn(C)c1)C1=Nc2c(C(=O)NC1)n(CCO)nc2C(C)(C)C |t:16| Show InChI InChI=1S/C23H28N6O3/c1-23(2,3)21-19-20(29(27-21)8-9-30)22(31)24-12-17(26-19)14-6-7-18(32-5)16(10-14)15-11-25-28(4)13-15/h6-7,10-11,13,30H,8-9,12H2,1-5H3,(H,24,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4B catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B (Homo sapiens (Human))	BDBM50491697 (CHEMBL2387424) Show SMILES COc1ccc(cc1-c1cnc(OC)nc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C25H30N6O5/c1-25(2,3)21-19-20(31(30-21)9-10-32)22(33)26-13-17(28-19)14-7-8-18(34-4)15(11-14)16-12-27-24(36-6)29-23(16)35-5/h7-8,11-12,32H,9-10,13H2,1-6H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	138	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of PDE4B catalytic domain (unknown origin)				Bioorg Med Chem Lett 23: 3443-7 (2013) Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 164 total )  |  Next  |  Last  >>

Jump to: